Back to LCT Homepage Targeting Huntington's Disease, Stroke, Type 1 Diabetes and Haemophilia
Living Cell Technologies
LCT - Living Cell Technologies
News updates: Subscribe
Unsubscribe


July 22, 2008
LCT Reports Clinical Benefits
July 17, 2008
LCT Hosts Seminar of World Leaders
July 14, 2008
LCT Quarterly Newsletter
July 11, 2008
Transcript of LCT interview with The Wall Street
June 26, 2008
LCT Informed of Progress for Diabetes Clinical Trial
 

Company Presentations


LCT AGM Presentation
November, 2006

LCT AGM Presentation November 2006 Download


LCT AusBiotech Presentation
November, 2006

LCT AusBiotech Presentation November 2006 Download

LCT - Living Cell Technologies
What is xenotransplantation?
The use of living animal cells, tissues or organs in human therapeutics. >more

What is DiabeCell?
DiabeCell is a porcine pancreatic cell product for the treatment of insulin-dependent diabetes. >more

What is NeurotrophinCell?
A choroid plexus (brain) cell product with the potential to treat diseases of the nervous system such as Huntington's disease and stroke. >more

What is LCT's encapsulation technology?
The living cells are covered in a seaweed-derived coating (alginate encapsulation) to form capsules which eliminate the
need for toxic immunosuppressant drugs and allow the release of beneficial factors.
>more
   
graphic design and website design - PDF Communications Ltd